A rendering of Novo Nordisk's planned new factory in Denmark (Novo Nordisk)
Novo Nordisk to spend $1.2B for new rare disease drug factory in Denmark
Just days after winning FTC approval to take on three of Catalent’s facilities, Novo Nordisk said it is investing DKK 8.5 billion …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
